PE/Cyanine7 anti-human CD158h (KIR2DS1) Antibody, CD158h, S22019F,BioLegend,335009

Based on in-house testing, clone S22019F does not react to other KIR protein family members.

Host

Mouse

Reactivity

Human

Application

FC - Quality tested

Platform ID

BAB449618546

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePE/Cyanine7 anti-human CD158h (KIR2DS1) Antibody, CD158h, S22019F
Cat. No.335009
HostMouse
RRIDAB_3717095 (BioLegend Cat. No. 335009)AB_3717095 (BioLegend Cat. No. 335010)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationFC - Quality tested
ClonalityMonoclonal
Clone NumberS22019F
ConcentrationLot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in ourCertificate of Analysisonline tool.)
TargetCD158h
ImmunogenKIR2DS1 transfected cells
PurityThe antibody was purified by affinity chromatography and conjugated with PE/Cyanine7 under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
StorageThe antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD158 molecules, also known as KIRs (killer cell immunoglobulin-like receptors), are a family of transmembrane proteins with either two (KIR2D) or three (KIR3D) Ig-like extracellular domains. Some KIRs with long cytoplasmic domains contain ITIMs and possess inhibitory functions and others with short cytoplasmic region lack ITIMs and have activation functions. Fifteen polymorphic KIR genes have been reported in humans. CD158h is a 50 kD, single-pass glycoprotein with two extracellular Ig domains that contains a short cytoplasmic tail and does not contain an intracellular ITIM domain. It is expressed primarily on a subset of NK cells and a subset of T cells. KIR2DS1 is reported to bind certain HLA-C antigens on target cells (HLA-C*02, HLA-C*04, HLAC*06, for example).

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.